Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Biomarker Strategic Engagement Lead will report to the Director of Biomarker Strategy and Execution, this role is responsible for shaping and managing strategic partnerships with local and regional labs and pathologists in academic institutions, community pathology groups, integrated delivery networks (IDNs), and broad pathology stakeholders to ensure actionable adoption of RAS biomarker testing for the purpose of standard of care testing and appropriate patient identification. This is a critical role within the biomarker team for Revolution Medicine’s portfolio of investigational RAS(ON) inhibitors, targeting RAS-addicted cancers. This position will be remotely based.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Bachelor's degree